Edition:
United States

Tetraphase Pharmaceuticals Inc (TTPH.OQ)

TTPH.OQ on NASDAQ Stock Exchange Global Select Market

1.29USD
3:59pm EST
Change (% chg)

$-0.10 (-7.19%)
Prev Close
$1.39
Open
$1.39
Day's High
$1.40
Day's Low
$1.28
Volume
241,452
Avg. Vol
165,563
52-wk High
$6.59
52-wk Low
$1.01

Select another date:

Mon, Aug 27 2018

FDA approves Tetraphase Pharma's antibiotic

Tetraphase Pharmaceuticals Inc said on Monday U.S. health regulators approved its drug to treat complicated intra-abdominal infections, providing a new option to combat the growing threat from treatment-resistant bacteria.

UPDATE 1-U.S. FDA approves Tetraphase Pharma's antibiotic

Aug 27 Tetraphase Pharmaceuticals Inc said on Monday U.S. health regulators approved its drug to treat complicated intra-abdominal infections, providing a new option to combat the growing threat from treatment-resistant bacteria.

U.S. FDA approves Tetraphase Pharma's antibiotic

Aug 27 The U.S. Food and Drug Administration on Monday approved Tetraphase Pharmaceuticals Inc's antibiotic for complicated intra-abdominal infections, providing a new option to combat the growing problem of treatment-resistant bacteria.

Select another date: